Changes in hepatic blood flow during whole body hyperthermia

International Journal of Hyperthermia

Volumn 26, Issue 2, 2010, Pages 95-100

  Deja, Maria ^a   Ahlers, Olaf ^a   MacGuill, Martin ^a   Wust, Peter ^a   Hildebrandt, Bert ^a   Riess, Hanno ^a   Kerner, Thoralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood flow distribution; Hepatic blood flow; Plasma disappearance rate of indocyanine green; Whole body hyperthermia

Indexed keywords

CARBOPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; INDOCYANINE GREEN; MITOMYCIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; CANCER CHEMOTHERAPY; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; FEASIBILITY STUDY; FEMALE; HEART OUTPUT; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; LIVER BLOOD FLOW; MALE; METASTASIS; NEOPLASM; OVARY CANCER; PLASMA CLEARANCE; WHOLE BODY HYPERTHERMIA;

ADULT; ANTINEOPLASTIC AGENTS; BLOOD PRESSURE; COLORING AGENTS; COMBINED MODALITY THERAPY; FEMALE; HEMODYNAMICS; HUMANS; HYPERTHERMIA, INDUCED; INDOCYANINE GREEN; LIVER CIRCULATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS;

EID: 77149121119     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656730903250574     Document Type: Article

References (24)

1. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487-497
2. Van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kadota Fund International Forum 2004-Clinical group consensus. Int J Hyperthermia 2008;24:111-122
3. Bull JM, Scott GL, Strebel FR, Nagle VL, Oliver D, Redwine M, Rowe RW, Ahn CW, Koch SM. Fever-range whole body thermal therapy combined with cisplatin, gemcitabine, and daily interferone--: A description of a phase I-II protocol. Int J Hyperthermia 2008;24:649-662
4. Song CW, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005;21:761-767
5. Vaupel P, Kallinowski F, Kluge M, Egelhof E, Fortmeyer HP. Microcirculatory and pH alterations in isotransplanted rat and xenotransplanted human tumors associated with hyperthermia. Recent Results Cancer Res 1988;109:174-182
6. Xu Y, Choi J, Hylander B, Sen A, Evans SS, Kraybill WG, Repasky EA. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxirubicin. Int J Hyperthermia 2007;23:513-527
7. Bull JM, Strebel FR, Jenkins GN, Deng W, Rowe RW. The importance of schedule in whole body thermochemotherapy. Int J Hyperthermia 2008;24:171-181
8. Hildebrandt B, Wust P. Interactions between hyperthermia and cytotoxic drugs. Cancer Treat Res 2007;134:185-193
9. Jones EI, Prosnitz LR, Dewhirst MW, Marcom PK, Hardenbergh PH, Marks LB, Brizel DM, Vujaaskovic Z. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 2004;10:4287-4293
10. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-410
11. Sonveaux P. Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment. Radiotherapy Oncol 2008;86:300-313
12. Lüdemann L, Wust P, Gellermann J. Perfusion management using DCE-MRI: Implications for Hyperthermia. Int J Hyperthermia 2008;24: 91-96
13. Lautt WW. Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, and escape from vasoconstriction. Hepatol Res 2007;37: 891-903
14. Hinghofer-Szalkay HG, Goswami N, Rö ssler A, Grasser E, Scgneditz D. Reactive hyperemia in the human liver. Am J Physiol Gastrointest Liver Physiol 2008;295:332-337
15. Rowell LB, Detry JMR, Blackmon JR, Wyss C. Importance of the splanchnic vascular bed in human blood pressure regulation. J Appl Physiol 1972;32:213-220
16. Deja M, Hildebrandt B, Ahlers O, Riess H, Wust P, Gerlach H, Kerner T. Goal-directed therapy of cardiac preload in induced whole-body hyperthermia. Chest 2005;128:580-586
17. Hildebrandt B, Dräger J, Kerner T, Deja M, Lö ffel J, Stroszczynski C, Ahlers O, Felix R, Riess H, Wust P. Whole-body hyperthermia in the scope of von Ardenne's 'systemic Cancer Multistep Therapy sCMT' combined with chemotherapy in patients with metastatic colorectal cancer - A phase I/II study. Int J Hyperthermia 2004;20:317-333
18. Faybik P, Hetz H. Plasma disappearance rate of indocyanine green in liver dysfunction. Transplant Proc 2006;38:801-802
19. Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med 2004;30:506-509
20. Kunz HD, Schregel W. Indocyanine-green: Evaluation of liver function; application in intensive care medicine. In: Lewis FR and Pfeiffer UJ, editors. Practical applications in intensive care monitoring. Berlin, Heidelberg, New York: Springer; 1990. pp 57-62
21. Lichtwarck-Aschoff M, Zervavik J, Pfeiffer UJ. Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med 1992;18:142-147
22. Kerner T, Deja M, Ahlers O, Lö ffel J, Hildebrandt B, Wust P, Gerlach H, Riess H. Whole body hyperthermia: A secure procedure for patients with various malignancies? Intensive Care Med 1999;25:959-965
23. Faithfull NS, Reinhold HS, Van Den Berg AP, van Rhoon GC, van der Zee J, Wike-Hooley JL. Cardiovascular changes during whole body hyperthermia treatment of advanced malignancy. Eur J Appl Physiol 1984;53:274-281
24. Charkoudian N. Skin blood flow in adult human thermoregulation: How it works, when it does not, and why. Mayo Clin Proc 2003;78:603-612